| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0008 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.001 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.001 |